Home › Stocks › ANAB › All Fund Holders
ANAB — ANAPTYSBIO INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $599.53M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.84M | $124.47M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 1.54M | $74.85M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 822.32K | $55.51M | 0.02% | Add |
| Geode Capital Management history | Q2 2026 | 637.87K | $43.06M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 584.07K | $39.42M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 539.67K | $36.43M | 0.02% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 488.65K | $32.98M | 0.01% | Reduce |
| Bank of America Corp history | Q2 2026 | 417.81K | $28.20M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 263.00K | $17.75M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 257.09K | $17.35M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 240.51K | $16.23M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 202.77K | $13.69M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 202.31K | $13.66M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 202.06K | $13.64M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 146.83K | $9.91M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 106.95K | $7.22M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 99.11K | $6.69M | 0.00% | Add |
| Farallon Capital Management history | Q3 2024 | 183.88K | $6.16M | 0.03% | New |
| Prudential Financial history | Q2 2026 | 85.93K | $5.80M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 80.24K | $5.29M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 58.30K | $3.94M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 56.40K | $3.81M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 46.88K | $3.16M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 46.32K | $3.13M | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 55.30K | $3.07M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 43.82K | $2.96M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 41.80K | $2.82M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 41.71K | $2.82M | 0.00% | Add |
| CPP Investments history | Q2 2026 | 16.50K | $1.11M | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 16.41K | $1.11M | 0.00% | Add |
| MFS Investment Management history | Q2 2026 | 15.87K | $1.07M | 0.00% | New |
| Manulife Financial history | Q2 2026 | 10.37K | $699.71K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 8.60K | $580.50K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 7.46K | $413.88K | 0.00% | Hold |
| Balyasny Asset Management history | Q1 2026 | 4.91K | $272.03K | 0.00% | New |
| Principal Global Investors history | Q1 2023 | 10.66K | $232.03K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 104 | $7.02K | 0.00% | Reduce |
| Amundi US history | Q1 2025 | 256 | $4.94K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 32.37K | $2.19K | 0.00% | Add |
| Lazard Asset Management history | Q1 2025 | 5.52K | $102 | 0.00% | New |